
|Articles|November 15, 2002
Mini shunt diverts excess aqueous humor
Green Bay, WI-The recently introduced miniature glaucoma shunt (Ex-Press) is an exciting modality with a lot of potential, but this new IOP-lowering treatment still requires further study to define its long-term efficacy and place in the armamentarium of glaucoma management options, said James E. Memmen, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
From then to next: Five decades of transformation in ophthalmology
4
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
5


















































.png)


